Is it normal to have hematuria two weeks after ureteral stent placement for a kidney stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mild hematuria up to 2 weeks after ureteral stent placement is common and generally expected, but persistent or worsening bleeding warrants immediate evaluation.

Blood in the urine following ureteral stent placement is a recognized complication that can persist for days to weeks, but the severity and duration determine whether intervention is needed.

Understanding Post-Stent Hematuria

According to the most recent EAU guidelines, ureteral stent placement and extraction are classified as low-risk bleeding procedures 1. However, hematuria remains one of the most common stent-related symptoms:

  • Hematuria occurs in 52-57% of patients with ureteral stents 2
  • The bleeding typically results from mucosal irritation from the stent rubbing against the ureteral and bladder walls
  • Most cases involve microscopic or mild macroscopic hematuria that resolves spontaneously

When Hematuria Is Expected vs. Concerning

Expected (Normal) Hematuria:

  • Mild to moderate blood-tinged urine in the first 1-2 weeks
  • Intermittent bleeding that improves over time
  • Blood that clears with increased hydration
  • No associated fever, severe pain, or clot passage

Concerning (Abnormal) Hematuria at 2 Weeks:

  • Persistent heavy bleeding requiring clot evacuation
  • Bleeding that worsens rather than improves
  • Associated with severe flank pain, fever, or hemodynamic instability
  • Passage of large clots causing urinary retention

Serious Complications to Rule Out

While rare, several serious complications can cause persistent hematuria at 2 weeks 3, 4:

  1. Stent malposition - The proximal end may perforate renal parenchyma 3
  2. Perinephric hematoma - Can develop days after placement, especially with pre-existing infection 4
  3. Stent migration into the nephrostomy tract causing vascular injury 5
  4. Decompression hematuria - Particularly in chronic obstruction cases 6

Clinical Algorithm for Management

Immediate evaluation is needed if:

  • Hemoglobin drop or need for transfusion
  • Clot retention requiring catheterization
  • Fever suggesting infected hematoma
  • Severe uncontrolled pain

Workup should include:

  • Complete blood count to assess for anemia
  • Urinalysis and urine culture
  • KUB radiography to verify stent position 3
  • CT imaging if stent malposition or hematoma suspected 4

Conservative management is appropriate for mild cases:

  • Bed rest and increased oral hydration
  • NSAIDs for pain (if no contraindication)
  • Alpha-blockers improve stent tolerability 1
  • Antibiotics if infection suspected

Key Clinical Pitfalls

⚠️ Do not assume all post-stent hematuria is benign - While common, persistent bleeding at 2 weeks requires investigation to exclude stent malposition or parenchymal injury 3

⚠️ Patients with prolonged obstruction (>2 months) are at higher risk for complications including decompression hematuria and parenchymal perforation 3, 6

⚠️ Infected hematomas can develop days after initial placement - The combination of hematuria with fever mandates imaging and possible drainage 4

Bottom Line

Contact your urologist if the bleeding is heavy, worsening, associated with clots, or accompanied by fever or severe pain. Light blood-tinged urine that is stable or improving can be monitored, but any concerning features require prompt imaging to rule out stent malposition or other complications that may need repositioning or removal 3, 4.

Related Questions

What is the appropriate management for a left perinephric/subcapsular collection (infective collection/organized hematoma) with Grade I/II left renal parenchymal disease, bladder debris, and bilateral double‑J ureteral stents as described on ultrasound?
In an 88-year-old male with pyuria, a migrated ureteral stent that required exchange during admission, resolved acute kidney injury, negative urine culture, and mild‑to‑moderate left hydronephrosis with a residual ureteropelvic junction stone, should he be prescribed oral antibiotics at discharge?
How long are ureteral stents typically left in for hydronephrosis?
Is a 6 x 4 mm right-sided vesicoureteric junction (VUJ) stone causing mild right-sided hydroureteronephrosis an indication for complex ureteroscopy?
What is the likely cause of blood around the kidney after recent stent placement and how should it be evaluated and managed?
What is the next best investigation for a patient with a suspected enterocutaneous fistula and a history of recurrent omphalitis?
What are the risk factors for gallbladder stones and what non‑surgical treatment options are available?
What does a white blood cell count of 17.1 ×10⁹/L with unchanged differential percentages indicate, and how should it be managed?
What are the side effects of doxycycline and what holistic measures should be taken?
What does an absolute neutrophil count of approximately 10 × 10⁹/L indicate and how should it be managed?
Can you provide a USMLE-style clinical vignette question?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.